Results for tag: "Inflammatory Breast Cancer Drug"

Inflammatory Breast Cancer (IBC) is a rare and aggressive form of breast cancer that affects the skin and lymph nodes of the breast. It is characterized by rapid onset of symptoms, including redness, swelling, and warmth of the breast, as well as an orange-peel texture of the skin. Treatment for IBC typically involves a combination of chemotherapy, radiation, and surgery. Drugs used to treat IBC include targeted therapies, such as trastuzumab and pertuzumab, which target the HER2 protein found in some IBC tumors. Other drugs used to treat IBC include hormonal therapies, such as tamoxifen and aromatase inhibitors, which block the effects of estrogen on cancer cells. Immunotherapies, such as ipilimumab, are also used to treat IBC. The IBC drug market is a rapidly growing segment of the breast cancer drug market. It is driven by the increasing prevalence of IBC, as well as the development of new and more effective treatments. Some companies in the IBC drug market include Roche, Pfizer, AstraZeneca, Merck, and Novartis. Show Less Read more